l-S,R-buthionine sulfoximine: historical development and clinical issues
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 111-112 (1) , 239-254
- https://doi.org/10.1016/s0009-2797(97)00164-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.Proceedings of the National Academy of Sciences, 1995
- High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.Proceedings of the National Academy of Sciences, 1992
- Role of the Glutathione Redox Cycle in Acquired and de Novo Multidrug ResistanceScience, 1988
- Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathioneBiochemical Pharmacology, 1987
- Reduction in cellular glutathione by buthionine sulfbximine and sensitization of murine tumor cells resistant to L-phenylalanine mustardBiochemical Pharmacology, 1984
- GLUTATHIONEAnnual Review of Biochemistry, 1983
- Membrane transport, sulfhydryl levels and DNA cross-linking in Chinese hamster ovary cell mutants sensitive and resistant to melphalanBiochemical Pharmacology, 1983
- Dechlorination of l-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione contentBiochemical Pharmacology, 1983
- Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivityBiochemical Pharmacology, 1982
- Comparison of nitrogen-mustard-sensitive and -resistant yoshida sarcomasInternational Journal of Cancer, 1966